These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34670511)

  • 1. Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy.
    Takada K; Kashiwagi S; Asano Y; Goto W; Ishihara S; Morisaki T; Shibutani M; Tanaka H; Hirakawa K; Ohira M
    BMC Cancer; 2021 Oct; 21(1):1129. PubMed ID: 34670511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer.
    Takada K; Kashiwagi S; Asano Y; Goto W; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
    BMC Cancer; 2019 Jun; 19(1):615. PubMed ID: 31234828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Serum Albumin Levels and Body Mass Index on Outcomes of Open Abdominal Aortic Aneurysm Repair in Korean Population.
    Park JK; Park YJ; Yang SS; Kim DI; Kim YW
    Ann Vasc Surg; 2024 Apr; 101():139-147. PubMed ID: 38211897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in tumor-infiltrating lymphocyte density and prognostic factors for breast cancer by patient age.
    Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Shibutani M; Tanaka H; Hirakawa K; Ohira M
    World J Surg Oncol; 2022 Feb; 20(1):38. PubMed ID: 35177074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term and long-term outcomes of oesophagogastric surgery for cancer in obese and normal weight patients.
    Glatz T; Kulemann B; Kuvendjiska J; Fichtner-Feigl S; Hoeppner J
    ANZ J Surg; 2020 Mar; 90(3):277-282. PubMed ID: 31854089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body Mass Index as a Prognostic Factor in Resected Lung Cancer: Obesity or Underweight, Which Is the Risk Factor?
    Matsunaga T; Suzuki K; Imashimizu K; Banno T; Takamochi K; Oh S
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):551-7. PubMed ID: 26277079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Infiltrating Lymphocytes in Low-Risk Patients With Breast Cancer Treated With Single-Dose Preoperative Partial Breast Irradiation.
    Vasmel JE; Vreuls CPH; Manson QF; Charaghvandi RK; van Gorp J; van Leeuwen AMG; van Diest PJ; Verkooijen HM; van den Bongard HJGD
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1325-1331. PubMed ID: 33333201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer.
    Kashiwagi S; Asano Y; Goto W; Takada K; Takahashi K; Noda S; Takashima T; Onoda N; Tomita S; Ohsawa M; Hirakawa K; Ohira M
    PLoS One; 2017; 12(2):e0170634. PubMed ID: 28166544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment.
    Kashiwagi S; Tsujio G; Asano Y; Goto W; Takada K; Takahashi K; Morisaki T; Fujita H; Takashima T; Tomita S; Ohsawa M; Hirakawa K; Ohira M
    J Transl Med; 2018 Mar; 16(1):54. PubMed ID: 29523158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between absolute neutrophil count and lymphocyte-predominant breast cancer.
    Yoon CI; Park S; Cha YJ; Lee HS; Bae SJ; Cha C; Lee DY; Ahn SG; Jeong J
    Breast; 2020 Apr; 50():141-148. PubMed ID: 31607527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of body mass index on surgical outcomes after posterior spinal fusion for adolescent idiopathic scoliosis.
    De la Garza Ramos R; Nakhla J; Nasser R; Schulz JF; Purvis TE; Sciubba DM; Kinon MD; Yassari R
    Neurosurg Focus; 2017 Oct; 43(4):E5. PubMed ID: 28965443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer.
    Takada K; Kashiwagi S; Asano Y; Goto W; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
    J Transl Med; 2019 Jan; 17(1):13. PubMed ID: 30616624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between Molecular Subtypes and Stromal Immune Infiltration before and after Treatment in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Hamy AS; Bonsang-Kitzis H; De Croze D; Laas E; Darrigues L; Topciu L; Menet E; Vincent-Salomon A; Lerebours F; Pierga JY; Brain E; Feron JG; Benchimol G; Lam GT; Laé M; Reyal F
    Clin Cancer Res; 2019 Nov; 25(22):6731-6741. PubMed ID: 31515462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer by Subtype Using Tumor-infiltrating Lymphocytes.
    Asano Y; Kashiwagi S; Goto W; Takada K; Takahashi K; Hatano T; Takashima T; Tomita S; Motomura H; Ohsawa M; Hirakawa K; Ohira M
    Anticancer Res; 2018 Apr; 38(4):2311-2321. PubMed ID: 29599354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancer.
    Goto R; Hirota Y; Aruga T; Horiguchi S; Miura S; Nakamura S; Takimoto M
    Breast Cancer; 2020 Jul; 27(4):586-593. PubMed ID: 31933123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
    Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
    Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
    Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of body mass index on pathological complete response and survival of breast cancer patients receiving neoadjuvant chemotherapy.
    Aguiar D; Ros L; Pérez D; Croissier L; Mori M; Hernández M; Vargas AM; Galván S; Antonilli C; Saura S
    Breast Dis; 2022; 41(1):351-361. PubMed ID: 36031886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer.
    Takada K; Kashiwagi S; Asano Y; Goto W; Kouhashi R; Yabumoto A; Morisaki T; Shibutani M; Takashima T; Fujita H; Hirakawa K; Ohira M
    BMC Cancer; 2020 Jun; 20(1):598. PubMed ID: 32590956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.